Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
25.26B | 27.57B | 25.44B | 23.89B | 25.42B | Gross Profit |
9.09B | 10.03B | 10.26B | 12.44B | 15.71B | EBIT |
5.15B | 6.21B | 6.57B | 9.30B | 12.66B | EBITDA |
10.92B | 12.83B | 7.11B | 9.80B | 13.09B | Net Income Common Stockholders |
6.30B | 9.26B | 9.24B | 13.20B | 10.19B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
18.77B | 22.11B | 11.74B | 11.34B | 6.13B | Total Assets |
531.24B | 542.55B | 529.79B | 550.30B | 461.09B | Total Debt |
83.25B | 161.69B | 150.09B | 159.48B | 96.29B | Net Debt |
65.34B | 140.07B | 140.26B | 150.99B | 90.71B | Total Liabilities |
190.66B | 198.45B | 184.64B | 198.13B | 128.90B | Stockholders Equity |
322.15B | 326.54B | 327.95B | 335.02B | 327.61B |
Cash Flow | Free Cash Flow | |||
15.30B | 14.46B | 7.95B | -54.16B | 4.51B | Operating Cash Flow |
15.30B | 14.46B | 11.13B | 685.00M | 7.07B | Investing Cash Flow |
-1.87B | 16.00M | 12.15B | -50.04B | -974.00M | Financing Cash Flow |
-21.20B | -5.42B | -21.30B | 52.05B | -10.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $16.41B | 20.33 | 1.94% | 9.87% | -7.35% | -31.76% | |
75 Outperform | $14.21B | 27.45 | 5.19% | 4.76% | 12.55% | 45.10% | |
71 Outperform | $13.52B | 33.88 | 5.81% | 3.29% | 6.90% | 9.99% | |
69 Neutral | $12.09B | 42.87 | 3.26% | 7.16% | 23.65% | 12.82% | |
68 Neutral | $13.95B | 32.86 | 5.02% | 5.59% | -5.89% | -26.36% | |
68 Neutral | $12.63B | 33.74 | 22.87% | 3.27% | 0.69% | 5.67% | |
61 Neutral | $2.84B | 10.85 | 0.42% | 9.90% | 5.94% | -21.26% |